BioGenes shows latest PK and immunogenicity testing services at BIO-Europe Copenhagen


BioGenes shows latest PK and immunogenicity testing services at BIO-Europe Copenhagen


Druck

Press Release | BioGenes GmbH

OCTOBER 19, 2018

Berlin, Germany:- Leading force in host cell protein (HCP) assay development, BioGenes GmbH, will present its impressive range of services and products at Europe’s leading partnering event, BIO-Europe, in Copenhagen.

BioGenes will be an exhibitor at the event with a stand at Booth 56 at Copenhagen’s Bella Center. A particular highlight of the display will be BioGenes’ advanced tools and services for PK-and Immunogenicity testing of new biologics and biosimilars.

HCP and ELISA testing

This is a return to BIO Europe for BioGenes, who also attended last year’s conference in Berlin.

Representing BioGenes in Copenhagen will be a three-strong team headed by Marketing Director Dagmar Schwertner-Knoll, accompanied by Dr. Marieke Mohr and Dr. Martin Föge, a post-doctoral biologist who recently joined the company from University Hospital, Jena.

They will be able to present a range of advances made in BioGenes host cell protein (HCP) kits and ELISA testing services as part of a complete panel of services and products for quality control purposes of biological production. These include custom antibody development (pAbs, mAbs, anti-IDs), custom ELISA development and kit production, HCP assays, analytical services and feasibility studies.

Quality control of biological production

“We are delighted to be returning to BIO Europe, which is a key event for networking with potential partners and collaborators,” is the most important reason, partnering meetings, presentation of our services and products,” commented Dagmar Schwertner-Knoll.

“We will be showing a complete panel of services and products of very high relevance to anyone working in PK-and Immunogenicity testing of biologics and biosimilars. We hope possible clients who need highest quality control of biological production, including custom antibody development, assays, analytical services and feasibility studies will come to meet us on Copenhagen or get in touch via EBD’s partneringONE system,” she added.

About BioGenes GmbH

BioGenes GmbH (BioGenes) is an acknowledged global leader in host cell protein (HCP) assay development and a recognized partner of pharmaceutical companies all over the world. The Berlin-based company specializes in highly sophisticated and customized antibody and immunoassay development and is an experienced and reliable partner for process development improvements in all areas of quality control, diagnostics and drug discovery.

BioGenes is known as a trusted and experienced expert in immunoassay, 2D electrophoresis and antibody development with a business strategy focused on driving forward innovations for customers and building new strategic partnerships aimed at cementing its market leadership in host cell assay development.

BioGenes was founded in 1992 by Dr. Alexander Knoll (Managing Director) and Dr. Sergej Ovodov (Scientific Director), who are now sole owners following a management buyout in October 2015. Headquartered in Berlin, the company has a workforce numbering more than 50 people, most of them scientists.

The company maintains long-term relationships with research institutes, universities and biotech and pharmaceutical companies, including eight of the ten largest pharmaceutical companies in the world.

About BIO-Europe 2018

The BIO-Europe® Conference is Europe’s largest partnering event serving the global biotechnology industry, providing life science companies with high caliber knowledge sharing and partnering opportunities.

The 24th BIO-Europe Conference is a three-day event opening November 5 at the Bella Center, Copenhagen.

BIO-Europe 2018 will attract more than 4,000 industry attendees from some 60 countries, representing more than 2,100 companies for three days of high level networking. Partnering is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with multiple company targets.

BIO-Europe is organized by EBD Group and KNECT 365 with further information at: https://ebdgroup.knect365.com/bioeurope/about-bio-europe.

Media Contact

Dagmar Schwertner-Knoll, Marketing & Sales Director, BioGenes GmbH
Tel: +49 30 6576 2396
Email: dagmar.schwertner@biogenes.de

Resources

Click on BioGenes at BIO-Europe 2018 for more information.
Click on BioGenes to contact the company directly.


Supplier Information
Supplier: BioGenes GmbH
Address: Koepenicker Str. 325, D-12555 Berlin, Germany
Tel: +49 30 6576 2396
Fax: +49 30 6576 2397
Website: http://www.biogenes.de


Comments are closed.